Home/Filings/4/0001012975-19-000035
4//SEC Filing

GILL JOHN 4

Accession 0001012975-19-000035

CIK 0001326190other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 5:11 PM ET

Size

5.5 KB

Accession

0001012975-19-000035

Insider Transaction Report

Form 4
Period: 2019-01-02
GILL JOHN
Director
Transactions
  • Award

    Stock Options (option to buy)

    2019-01-02+20,00020,000 total
    Exercise: $2.60Exp: 2029-01-02Common Stock, par value $0.0001 (20,000 underlying)
Footnotes (1)
  • [F1]The option becomes vested and exercisable in two equal installments on February 28, 2019 and August 30, 2019, in each case, generally subject to the reporting person's continued service through the applicable vesting date.

Issuer

Altimmune, Inc.

CIK 0001326190

Entity typeother

Related Parties

1
  • filerCIK 0001409939

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:11 PM ET
Size
5.5 KB